Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Q1 2026 Net Sales Performance
ZBH logo

Zimmer Biomet Raises 2026 Guidance as Net Sales Climb 9.3% to $2.1 Billion

ZBH8-KFiling Date: 4/28/2026
Zimmer Biomet Holdings, Inc.
Description

What this story covers

Zimmer Biomet reported strong Q1 2026 results with 9.3% sales growth and significant margin expansion. Driven by its S.E.T. portfolio and Paragon 28 integration, the company raised full-year EPS guidance while returning $250 million to shareholders through buybacks.

Story snapshot

CompanyZimmer Biomet Holdings, Inc.
TickerZBH
VariantStandard detailed
Duration5:30
Filing type8-K
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0001193125-26-183411
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing8-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in